Masupirdine

Masupirdine
Identifiers
	IUPAC name 1-(2-bromophenyl)sulfonyl-5-methoxy-3-[(4-methylpiperazin-1-yl)methyl]indole;
PubChem CID	10073773;
DrugBank	DB06140;
ChemSpider	8249313;
UNII	8XZ281AO3G;
ChEMBL	ChEMBL4117187;
Chemical and physical data
Formula	C21H24BrN3O3S
Molar mass	478.41 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCN(CC1)CC2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4Br;
	InChI InChI=1S/C21H24BrN3O3S/c1-23-9-11-24(12-10-23)14-16-15-25(20-8-7-17(28-2)13-18(16)20)29(26,27)21-6-4-3-5-19(21)22/h3-8,13,15H,9-12,14H2,1-2H3; Key:GWCYPEHWIZXYFZ-UHFFFAOYSA-N;

Masupirdine is an investigational new drug that is being evaluated for the treatment of agitation in Alzheimer's dementia.^[1] It is a selective 5-HT₆ receptor antagonist.^[2]

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.